The Oxford BRC’s Theme Lead for Gene and Cell Therapy, Professor Robert MacLaren, has been ranked in the top 100 ophthalmologists worldwide for 2024 by the international Ophthalmologist magazine.
The ranking was based on votes from key leaders across ophthalmology, academia and industry.
Professor MacLaren is one of only ten retinal surgeons worldwide to be included on this list.
Many of his achievements have been first in human gene therapy clinical trials for blindness that he has led successfully at the John Radcliffe Hospital.
He said: “I am delighted that our work in Oxford has been recognised by this international committee. Oxford is the ideal place for first in human clinical trials. We have the ideal mix of world-leading scientists including Nobel laureates and highly specialised expert clinicians – all supported by outstanding clinical research governance teams.”